|
Proto-Oncogene Proteins c-akt
|
D051057 |
[Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells.
] |
|
Oncogene Protein v-akt
|
D051058 |
[A viral oncoprotein originally isolated from a murine T CELL LYMPHOMA infected with the acutely transforming retrovirus AKT8. v-akt protein is the viral homologue of PROTO-ONCOGENE PROTEINS C-AKT.
] |
|
nacrein
|
C101387 |
|
|
PTEN Phosphohydrolase
|
D051059 |
[A lipid phosphatase that contains a C2 DOMAIN and acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION.
] |
|
3-((N',N'-diguanidinoethylaminoethyl)carbamoyl)cholesterol
|
C101388 |
|
|
3-(N(4)-(N(1),N(8)-diguanidinospermidine)carbamoyl)cholesterol
|
C101389 |
|
|
Cytochrome P-450 CYP2D6 Inhibitors
|
D065690 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6.
] |
|
Cytochrome P-450 CYP2E1 Inhibitors
|
D065691 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2E1.
] |
|
Cytochrome P-450 CYP3A Inhibitors
|
D065692 |
[Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.
] |
|
Cytochrome P-450 Enzyme Inducers
|
D065693 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 ENZYMES.
] |
|
Cytochrome P-450 CYP1A2 Inducers
|
D065694 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP1A2.
] |
|
Cytochrome P-450 CYP2B6 Inducers
|
D065695 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2B6.
] |
|
Cytochrome P-450 CYP2C8 Inducers
|
D065696 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2C8.
] |
|
Cytochrome P-450 CYP2C19 Inducers
|
D065697 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2C19.
] |
|
Cytochrome P-450 CYP2C9 Inducers
|
D065698 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2C9.
] |
|
Cytochrome P-450 CYP2D6 Inducers
|
D065699 |
[Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP2D6.
] |
|
sialyl-2-3-galactosyl-1-4-xylosyl-1-(4-methylumbelliferone)
|
C101395 |
|
|
glycyl-arginyl-alanyl-aspartyl-seryl-proline
|
C101396 |
|
|
anti-dopamine beta-hydroxylase immunotoxin
|
C101397 |
|
|
STO1 protein, S cerevisiae
|
C101398 |
|